Skip to main content
. 2021 Aug 11;145(1):208–223. doi: 10.1093/brain/awab299

Figure 1.

Figure 1

Phenotypic spectrum associated with de novo DHDDS variants. (A) Prevalence of signs and symptoms in patients with de novo DHDDS variants (n = 25). (B) Frequency of the core clinical features in patients with de novo DHDDS variants. (C) Frequency of movement disorder (MD) subtypes; 20 of 25 patients had >1 movement disorder subtype. (D) Frequency of seizure types. (E) Frequency of neuropsychiatric features. The number of affected patients is reported in each graph bar (BE).